Salvia Rosmarinus Flowering Top

Dosage for Salvia Rosmarinus Flowering Top is highly individualized and must be determined by an allergy specialist based on the patient's sensitivity levels. There is no 'standard' dose because this is a non-standardized extract.

Diagnostic Testing (Skin Prick Test)

For adults, a single drop of the 1:10 or 1:20 w/v extract is applied to the skin (usually the forearm or back), and the skin is pricked through the drop. A positive control (histamine) and a negative control (saline/glycerin) are used simultaneously. The results are read after 15 to 20 minutes.

Immunotherapy (Subcutaneous Injection)

• Build-up Phase: Treatment typically begins with a very low dose (e.g., 0.05 mL of a 1:10,000 w/v dilution). Injections are given once or twice weekly, with the dose increasing by 50% to 100% each time, provided no significant local or systemic reactions occur.
• Maintenance Phase: Once the 'top dose' is reached (often 0.5 mL of a 1:10 or 1:20 w/v concentration), the frequency of injections is decreased to once every 2 to 4 weeks. This phase usually continues for 3 to 5 years.

Salvia Rosmarinus Flowering Top may be used in children, but extreme caution is required.

• Children under 5 years: Immunotherapy is generally avoided unless the allergy is severe and avoidance is impossible, due to the difficulty of the child communicating early symptoms of a systemic reaction.
• Children 5 years and older: Dosing follows a similar titration schedule to adults but may start at even lower concentrations. The volume of the injection is often capped at a lower maximum (e.g., 0.3 mL instead of 0.5 mL) depending on the child's size and sensitivity.

Renal Impairment

No specific dose adjustments are required for renal impairment, as the systemic protein load is negligible. However, patients with severe renal disease may have altered skin reactivity or may be taking medications that interfere with the treatment of a potential systemic reaction.

Hepatic Impairment

No dosage adjustments are defined for hepatic impairment. The metabolic clearance of these proteins is not significantly impacted by liver function.

Elderly Patients

Elderly patients (over 65) may have reduced skin reactivity, leading to potential false-negative results in diagnostic testing. Furthermore, the risk-benefit ratio for immunotherapy must be carefully weighed in the elderly, especially those with underlying cardiovascular disease, as they may not tolerate the epinephrine required to treat a systemic reaction.

This medication is never self-administered by the patient at home. It must be administered by a trained healthcare professional in a medical facility.

• Preparation: The vial should be inspected for particulate matter or discoloration. It should be kept refrigerated at 2°C to 8°C (36°F to 46°F).
• Administration: For immunotherapy, the injection is given subcutaneously (under the skin), usually in the posterior aspect of the upper arm. The site should not be massaged after injection.
• Observation: Patients must remain in the doctor's office for at least 30 minutes following any injection or skin test to monitor for signs of anaphylaxis.

If a dose of immunotherapy is missed:

• 1 week late: The usual dose may often be given.
• 2-4 weeks late: The dose may need to be reduced to the previous level in the titration schedule.
• Over 4 weeks late: The healthcare provider may need to restart the titration from a much lower concentration to ensure safety.

An 'overdose' in the context of allergenic extracts usually refers to an accidental injection of a higher concentration than intended or a dose that exceeds the patient's current tolerance.

• Signs: Rapid onset of hives, swelling of the throat, wheezing, low blood pressure, or loss of consciousness.
• Emergency Measures: Immediate administration of epinephrine (0.3 mg for adults), oxygen, intravenous fluids, and antihistamines. The patient must be transported to an emergency department for extended observation.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to self-administer this extract without medical guidance.

Most patients undergoing testing or treatment with Salvia Rosmarinus Flowering Top will experience some form of local reaction. These are generally considered expected and not 'adverse' unless they are excessively large.

• Local Wheal and Flare: During skin testing, a raised, itchy red bump is the expected result if the patient is allergic. This typically resolves within 1-2 hours.
• Injection Site Redness: In immunotherapy, redness at the site of the shot is very common. It may feel warm to the touch.
• Local Swelling: A small amount of swelling (less than the size of a half-dollar coin) at the injection site is common and may last for 24 hours.
• Pruritus (Itching): Itching at the site of administration is a frequent occurrence due to local histamine release.

• Large Local Reactions (LLR): Swelling that exceeds 5-10 cm in diameter. This may be uncomfortable and can be treated with cold compresses and oral antihistamines.
• Fatigue: Some patients report feeling unusually tired for several hours after an immunotherapy injection.
• Headache: Mild tension-type headaches have been reported following the administration of allergenic extracts.
• Nasal Congestion: A mild 'hay fever' like response may occur shortly after the injection.

• Urticaria (Hives): Generalized hives appearing on parts of the body away from the injection site.
• Angioedema: Swelling of the deeper layers of the skin, often around the eyes or lips.
• Vasovagal Syncope: Fainting or lightheadedness due to the needle prick or the stress of the procedure, rather than the extract itself.

> Warning: Stop taking Salvia Rosmarinus Flowering Top and call your doctor immediately if you experience any of these symptoms of a systemic reaction or anaphylaxis.

• Anaphylaxis: A life-threatening, multi-system allergic reaction. It often begins with a 'sense of impending doom,' followed by itching of the palms/soles, hives, and respiratory distress.
• Bronchospasm: Sudden constriction of the airways, leading to wheezing, chest tightness, and difficulty breathing. This is more common in patients with pre-existing asthma.
• Laryngeal Edema: Swelling of the throat or vocal cords, which can lead to airway obstruction. Symptoms include a 'lump in the throat' or a hoarse voice.
• Hypotension (Shock): A dangerous drop in blood pressure, which may cause dizziness, confusion, or loss of consciousness.
• Cardiac Arrest: In extremely rare cases of severe anaphylaxis, the heart may stop beating.

There are no known long-term 'toxic' effects of Salvia Rosmarinus Flowering Top, as it is a natural protein extract. However, the primary long-term risk is the development of 'serum sickness' or other immune-complex mediated diseases, though this is exceedingly rare with modern purified extracts. Some patients may develop a persistent nodule (granuloma) at the site of repeated injections if an aluminum-adsorbed extract is used.

While Salvia Rosmarinus Flowering Top itself may not always carry a specific brand-name black box warning, the entire class of allergenic extracts is subject to a general FDA-mandated warning regarding the risk of severe systemic reactions.

Summary of Warning:

• Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis and death.
• They should only be administered by healthcare providers prepared to manage such reactions.
• Patients with unstable asthma are at increased risk for fatal reactions.
• Extracts should be used with caution in patients taking beta-blockers, as they may be unresponsive to epinephrine.

Report any unusual symptoms to your healthcare provider. Even a 'mild' systemic reaction (like a few hives) must be reported, as it often precedes a more severe reaction in future doses.

Salvia Rosmarinus Flowering Top is intended for use only by physicians who are experienced in the administration of allergenic extracts and the management of allergic diseases. Because of the risk of severe systemic reactions, patients must be observed for at least 30 minutes in the clinic following administration. Patients should be instructed to avoid vigorous exercise for several hours after an injection, as increased circulation can speed up the absorption of the allergen and increase the risk of a reaction.

No specific FDA black box warning exists for Salvia Rosmarinus Flowering Top specifically, but it falls under the class-wide warning for allergenic extracts. This warning emphasizes that these products can cause anaphylaxis and should only be used in facilities equipped with emergency equipment (epinephrine, oxygen, IV fluids, and airway management tools).

• Anaphylaxis Risk: This is the most significant risk. Patients with a history of high sensitivity or previous systemic reactions to other allergens are at higher risk. The risk is also increased during the 'build-up' phase of immunotherapy.
• Asthma Status: Patients with symptomatic or poorly controlled asthma should not receive Salvia Rosmarinus Flowering Top. A peak flow meter or spirometry may be used to assess lung function before each injection. If the patient's FEV1 is significantly below their baseline, the injection should be deferred.
• Cardiovascular Disease: Patients with significant heart disease (e.g., recent MI, unstable angina, or severe hypertension) are at higher risk of complications if they experience anaphylaxis or if they require large doses of epinephrine.
• Infection/Illness: Injections should be deferred if the patient has an active infection, fever, or respiratory illness, as these conditions can lower the threshold for a systemic allergic reaction.

• Pre-Injection Assessment: Before every dose, the provider must ask about reactions to the previous dose, current asthma symptoms, and any new medications (especially beta-blockers).
• Post-Injection Observation: Mandatory 30-minute wait time. The injection site must be checked for local swelling before the patient leaves.
• Lung Function: For asthmatic patients, regular monitoring of FEV1 or peak expiratory flow is recommended.

Salvia Rosmarinus Flowering Top does not generally cause sedation. However, if a patient experiences a vasovagal reaction (fainting) or a systemic reaction, they should not drive until they are fully recovered and cleared by a physician.

Alcohol consumption should be avoided on the day of an immunotherapy injection. Alcohol can cause vasodilation (widening of blood vessels), which may potentially increase the speed of allergen absorption or mask the early symptoms of an allergic reaction.

Immunotherapy with Salvia Rosmarinus Flowering Top is typically discontinued if:

1. 1The patient experiences a life-threatening systemic reaction.
2. 2The patient fails to show clinical improvement after 12-24 months of maintenance therapy.
3. 3The patient becomes non-compliant with the observation period or the dosing schedule.

> Important: Discuss all your medical conditions with your healthcare provider before starting Salvia Rosmarinus Flowering Top.

• Non-Selective Beta-Blockers: Drugs like propranolol or nadolol are generally contraindicated in patients receiving allergenic extracts. Clinical Consequence: If the patient has an anaphylactic reaction, beta-blockers can block the effects of epinephrine (adrenaline), making the reaction much harder to treat and potentially fatal.

• Selective Beta-Blockers: While less dangerous than non-selective ones, drugs like atenolol or metoprolol still carry a risk of interfering with epinephrine's efficacy. Use requires a careful risk-benefit analysis.
• ACE Inhibitors: Drugs used for blood pressure (e.g., lisinopril, enalapril). Clinical Consequence: These may increase the risk of severe systemic reactions or worsen the hypotension (low blood pressure) associated with anaphylaxis.
• MAO Inhibitors (MAOIs): Used for depression (e.g., phenelzine). Clinical Consequence: These can potentiate the effects of epinephrine, leading to a hypertensive crisis (dangerously high blood pressure) if epinephrine is used to treat a reaction.

• Antihistamines: Drugs like cetirizine, loratadine, or diphenhydramine. Clinical Consequence: These will suppress the 'wheal and flare' response during diagnostic skin testing, leading to false-negative results. Management: Patients must stop taking most antihistamines 3 to 7 days before skin testing.
• Tricyclic Antidepressants (TCAs): Like amitriptyline. These can also interfere with skin test results and may potentiate the effects of epinephrine.
• Systemic Corticosteroids: High doses of prednisone may slightly suppress skin test reactivity, though they are often continued during immunotherapy to manage asthma.

• Cross-Reactive Foods: Patients allergic to Salvia Rosmarinus may also react to other members of the Lamiaceae (mint) family, such as oregano, basil, thyme, or sage. Consuming large amounts of these spices shortly before or after an injection may theoretically increase the risk of a reaction.
• High-Fat Meals: There is no direct interaction, but heavy meals may cause gastrointestinal discomfort that could be confused with the early signs of an allergic reaction.

• St. John's Wort: May theoretically interact with the metabolism of other medications, though its effect on allergenic extracts is unknown.
• Ginkgo Biloba: Has mild anti-platelet effects; while not a direct interaction, it is generally advised to disclose all herbal use to the allergist.

• Total IgE: Treatment with Salvia Rosmarinus Flowering Top may cause a transient rise in total serum IgE levels during the build-up phase.
• Specific IgE (ImmunoCAP): Levels of rosemary-specific IgE may decrease over long-term successful immunotherapy, while specific IgG4 levels will increase.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter eye drops or nose sprays can contain ingredients that affect your treatment.

Salvia Rosmarinus Flowering Top must NEVER be used in the following circumstances:

1. 1Severe, Uncontrolled Asthma: Patients with an FEV1 persistently below 70% of predicted value or those with frequent acute exacerbations. Why: These patients are at an extremely high risk of a fatal bronchospasm if a systemic reaction occurs.
2. 2Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. Why: The heart may not tolerate the stress of a systemic reaction or the pharmacological effects of the epinephrine used to treat it.
3. 3History of Severe Anaphylaxis to this Specific Extract: If a previous attempt at immunotherapy resulted in a near-fatal reaction despite proper dosing.
4. 4Hypersensitivity to Diluent Components: Such as a known severe allergy to phenol (used as a preservative) or glycerin.

These conditions require a careful risk-benefit analysis by the allergist:

• Pregnancy: Immunotherapy is generally not started during pregnancy, though it may be continued at a maintenance dose if already well-tolerated. The risk is that anaphylaxis in the mother can cause fetal hypoxia (lack of oxygen).
• Autoimmune Diseases: Such as systemic lupus erythematosus (SLE) or rheumatoid arthritis. There is a theoretical concern that stimulating the immune system could worsen the underlying autoimmune condition.
• Malignancy: Patients with active cancer may have altered immune responses.
• Beta-Blocker Therapy: As discussed, this makes treating a reaction significantly more difficult.

Patients who are sensitive to Salvia Rosmarinus Flowering Top may show cross-sensitivity to:

• Other Salvia species (e.g., Sage).
• Other Lamiaceae family members (Lavender, Oregano, Thyme, Basil, Mint).
• Birch Pollen: Some studies suggest a potential cross-reactivity between certain tree pollens and spices (the 'pollen-food allergy syndrome').

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Salvia Rosmarinus Flowering Top.

Pregnancy Category C (Traditional): There are no adequate and well-controlled studies in pregnant women.

• Risks: The primary risk is not the extract itself, but the potential for maternal anaphylaxis, which can lead to uterine contractions, placental abruption, or fetal distress/death due to hypoxia.
• Clinical Guidance: Experts generally recommend against initiating Salvia Rosmarinus Flowering Top immunotherapy during pregnancy. If a patient is already on a stable maintenance dose and is tolerating it well, the physician may choose to continue the therapy, but the dose is typically not increased until after delivery.

It is not known whether the components of Salvia Rosmarinus Flowering Top are excreted in human milk. However, because these are large proteins that are likely digested in the infant's gut, the risk to a nursing infant is considered negligible. The primary concern remains the mother's safety and the potential need for emergency medications like epinephrine, which is considered compatible with breastfeeding in emergency situations.

• Approval: Salvia Rosmarinus Flowering Top is used in children, but the safety profile is less established in children under the age of 5.
• Special Considerations: Children may have difficulty describing the early 'aura' of an allergic reaction (e.g., itchy throat, strange taste in the mouth). Close observation by both the medical staff and the parent is required. Dosage is often adjusted based on the child's weight and the severity of their symptoms.

• Pharmacokinetic Changes: Older adults may have thinner skin, which can affect the interpretation of skin prick tests.
• Comorbidities: The presence of underlying cardiovascular or pulmonary disease in the elderly significantly increases the risk associated with immunotherapy.
• Polypharmacy: Elderly patients are more likely to be taking beta-blockers or ACE inhibitors, which complicate the safety profile of allergenic extracts.

There are no specific guidelines for renal impairment. The protein load in a 0.5 mL injection is minimal and does not pose a risk to kidney function. However, the patient's overall health and ability to tolerate emergency treatment should be considered.

No dosage adjustments are required for patients with liver disease. The liver's role in processing these specific allergenic proteins is minimal compared to the local tissue and lymphatic degradation.

> Important: Special populations require individualized medical assessment. Always inform your allergist if you are pregnant, planning to become pregnant, or have any chronic health conditions.

Salvia Rosmarinus Flowering Top acts as an exogenous (external) antigen. In diagnostic testing, it cross-links IgE antibodies on the surface of cutaneous mast cells, leading to the release of pre-formed mediators like histamine.

In immunotherapy, the mechanism involves a complex modulation of the immune system:

1. 1T-Cell Modulation: It induces the production of Regulatory T-cells (Tregs), which secrete IL-10 and TGF-beta, suppressing the Th2-mediated allergic response.
2. 2B-Cell Switch: It promotes a shift in antibody production from IgE to IgG4. IgG4 acts as a 'blocking antibody,' competing with IgE for the allergen binding sites.
3. 3Mast Cell/Basophil Desensitization: Over time, the threshold for degranulation of these cells is increased.

• Onset of Action: For skin testing, the onset is rapid (15-20 minutes). For immunotherapy, clinical improvement typically takes 6 to 12 months of regular injections.
• Duration of Effect: The diagnostic effect lasts only as long as the extract is present in the skin. The therapeutic effect of immunotherapy can last for several years after the 3-5 year course is completed.

| Parameter | Value |

|---|---|

| Bioavailability | N/A (Subcutaneous/Local) |

| Protein Binding | Primarily binds to IgE and IgG antibodies |

| Half-life | Proteins cleared within 24-48 hours; Immunological effect lasts years |

| Tmax | 15-30 minutes (local reaction) |

| Metabolism | Proteolysis in tissues and lymphatics |

| Excretion | Minimal renal excretion of peptide fragments |

• Composition: A complex mixture of proteins, glycoproteins, and polysaccharides. It also contains trace amounts of rosemary essential oils (terpenes).
• Molecular Weight: Ranges from 10 kDa to over 70 kDa for the primary allergenic proteins.
• Solubility: Soluble in aqueous buffers and glycerin-saline solutions.

Salvia Rosmarinus Flowering Top is a Non-Standardized Food Allergenic Extract. It is related to other spice extracts like Thymus vulgaris (Thyme) and Salvia officinalis (Sage).